Le Lézard
Classified in: Health, Science and technology

Demystifying Goal Attainment Scaling: Personalized Endpoints in FDA Patient-Focused Drug Development, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about the applications of Goal Attainment Scaling (GAS) in patient-focused clinical drug development. Attendees will learn the how-tos of GAS, the history and how the method works. The featured speakers will discuss the quantitative and qualitative interpretation of GAS data. The speakers will also discuss techniques to standardize the implementation of GAS in clinical trials. Attendees will learn the strengths and weaknesses of GAS outlined in the FDA draft Guidance 4.

TORONTO, June 9, 2023 /PRNewswire-PRWeb/ -- Patient Reported Outcome Measures (PROMs) are increasingly included in clinical development research to capture the patient experience. In April 2023, the US Food and Drug Administration (FDA) published the patient-focused drug development draft Guidance 4, Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making. This guidance outlines the potential value of personalized endpoints, such as Goal Attainment Scaling (GAS), in capturing meaningful change.

The webinar will introduce Goal Attainment Scaling, including its use history and applications throughout the clinical development lifecycle. The discussion will also include practical considerations for the standardized implementation of GAS in clinical development. Finally, the featured speakers will address the strengths and weaknesses of Goal Attainment Scaling as articulated in the FDA draft Guidance 4.

Join this webinar to learn about the applications of Goal Attainment Scaling in patient-focused clinical drug development.

Join experts from Ardea Outcomes, Chère Chapman, CEO; and Gunes Sevinc, Research Manager, for the live webinar on Friday, June 23, 2023, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Demystifying Goal Attainment Scaling: Personalized Endpoints in FDA Patient-Focused Drug Development.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com


These press releases may also interest you

at 16:45
TriNet , a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs), today announced that Kelly Tuminelli, TriNet's CFO, will be presenting at Deutsche Bank's 31st Annual Leveraged Finance Conference in...

at 16:35
QE Solar ("QE"), the leading national Operations and Maintenance (O&M) provider in the Commercial and Industrial (C&I) sector of US solar, is pleased to announce it has acquired Tritium3 Renewable Services, a...

at 16:34
In support of tech education in Kansas, Twin Valley has awarded a scholarship to more than 100 Kansas educators to attend the highly anticipated 2nd Annual Ad Astra Technology Summit, presented by state tech industry organization FlagshipKansas.Tech....

at 16:30
Nyxoah Announces Partnership with ResMed in GermanyCreates a continuum of care in the German obstructive sleep apnea market Mont-Saint-Guibert, Belgium ? September 28, 2023, 10:30pm CET / 4:30pm ET ? Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...

at 16:30
Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, will announce its financial results for the third quarter of 2023 before the market opens on Friday, November 3, 2023. A conference call with...

at 16:30
PTC Therapeutics, Inc. announced today further strategic prioritization and associated workforce reduction. The portfolio prioritization continues the process initiated in May 2023 as the company continues to focus its resources on its...

News published on and distributed by: